Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member

Search

1728222

registered interest
date	09/09/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genito-urinary Medicine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of creating a new Sexual Health Strategy.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Adam Jogee
uin	4790
answer	answer is ministerial correction date of answer 12/09/2024 answer text <p>We are committed to improving sexual heath in England for the whole population, and are currently considering the next steps in doing so. My Rt hon. Friend, the Secretary of State for Health and Social Care has commissioned officials for advice on how to progress the development of a new HIV Action Plan, which we aim to publish by summer 2025.</p><p>The Government is also committed to prioritising women's health as we build a National Health Service fit for the future. We are considering how to take forward the Women's Health Strategy for England.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne question first answered 12/09/2024 15:22:52 answering member 1506 label Biography information for Andrew Gwynne
tabling member	5168

1728258

registered interest
date	09/09/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prostate Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential benefits of introducing national screening for prostate cancer.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Adam Jogee
uin	4826
answer	answer is ministerial correction date of answer 12/09/2024 answer text <p>Screening for prostate cancer is currently not recommended by the UK National Screening Committees (UK NSC). This is because of the inaccuracy of the current best test, the Prostate Specific Antigen (PSA). A PSA-based screening programme could harm men, as some of them would be diagnosed with a cancer that would not have caused them problems during their life. This would lead to additional tests and treatments which can also have harmful side effects.</p><p>The UK NSC is currently carrying out an evidence review for prostate cancer screening, which includes different potential ways of screening the whole population from 40 years of age onwards, and targeted screening programme aimed at groups of men identified as being at higher than average risk, such as those with a family history, carriers of the BRCA2 gene, or based on ethnicity.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne question first answered 12/09/2024 15:18:31 answering member 1506 label Biography information for Andrew Gwynne
tabling member	5168

1726832

registered interest
date	02/09/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospices: Newcastle-under-Lyme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the (a) provision and (b) funding of hospice care in Newcastle-under-Lyme constituency.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Adam Jogee
uin	3883
answer	answer is ministerial correction date of answer 10/09/2024 answer text <p>Palliative care services are included in the list of services an integrated care board (ICB), including the Staffordshire and Stoke-on-Trent ICB, which covers Newcastle-under-Lyme, must commission. This promotes a more consistent national approach and supports commissioners in prioritising palliative and end of life care. To support the ICBs in this duty, NHS England has published statutory guidance and service specifications.</p><p>Whilst the majority of palliative and end of life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people, and their loved ones, at the end of life.</p><p>Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding charitable hospices receive varies by ICB area, and will, in part, be dependent on the breadth and range of palliative and end of life care provision within their ICB footprint.</p><p>We understand that, financially, times are difficult for many voluntary and charitable organisations, including hospices, due to the increased cost of living. We want a society where these costs are manageable for both voluntary organisations, like hospices, and the people whom they serve.</p><p>We, alongside NHS England, will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, in order to understand the issues they face.</p> answering member constituency Aberafan Maesteg answering member printed Stephen Kinnock question first answered 10/09/2024 11:01:52 answering member 4359 label Biography information for Stephen Kinnock
tabling member	5168

1726049

registered interest
date	30/08/2024
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Per- and Polyfluorinated Alkyl Substances
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, if he will take steps to phase out per-and-polyfluorinated alkyl substances (PFAS); and whether he plans to align with EU regulation standards on PFAS.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Adam Jogee
uin	3449
answer	answer is ministerial correction date of answer 09/09/2024 answer text <p>The Government is charting a new course to develop an ambitious programme to turn the tide and better protect our natural environment. Recently we announced a rapid review of the Environmental Improvement Plan to deliver on our legally binding targets to save nature. This includes how best to manage chemicals, including the risks posed by PFAS. We have already announced plans to restrict firefighting foams and will set out more detail in due course.</p> answering member constituency Kingston upon Hull West and Haltemprice answering member printed Emma Hardy question first answered 09/09/2024 13:37:13 answering member 4645 label Biography information for Emma Hardy
tabling member	5168

1726050

registered interest
date	30/08/2024
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Chemicals: Labelling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, pursuant to the Answer of 7 February 2023 to Question 138258 on Labelling: Packaging, what the UK's policy has been on matters relating to the meetings of the potential hazards issues working group established by the UN Globally Harmonized System of Classification and Labelling of Chemicals; and whether the UK (a) supported, (b) opposed or (c) did not taken a position in response to EU proposals to introduce new hazard classes on endocrine disruptors and other hazards.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Adam Jogee
uin	3450
answer	answer is ministerial correction date of answer 09/09/2024 answer text <p>The UK is an active participant of the potential hazard issues informal working group at the United Nations Globally Harmonized System of classification and labelling of chemicals (UN GHS) and supported a mandate issued to the Organisation for Economic Cooperation and Development (OECD) to conduct a state of the science review for endocrine disruptors, persistence and mobility. The mandate includes a review of the existing GHS hazard classes to inform technical discussions on the extent to which the potential hazard issues raised by the European Union (EU) delegation are addressed by existing GHS hazard classes.</p><p> </p><p>There are no plans to consider the suitability of establishing new hazard classes in the Great Britain Classification, Labelling and Packaging (GB CLP) Regulation without consensus at UN GHS. The UK is committed to following the established process at UN GHS and will consider the reviews from the OECD, in addition to input from a range of policy and technical experts, both within HSE and other UK government departments and agencies, to assist in the development of the UK policy position when a proposal is agreed at working group level.</p> answering member constituency East Ham answering member printed Sir Stephen Timms question first answered 09/09/2024 11:37:09 answering member 163 label Biography information for Sir Stephen Timms
tabling member	5168

1726054

registered interest
date	30/08/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bladder Cancer: Newcastle-under-Lyme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to help ensure that people with bladder cancer in Newcastle-under-Lyme constituency receive (a) an early diagnosis and (b) swift treatment.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Adam Jogee
uin	3451
answer	answer is ministerial correction date of answer 10/09/2024 answer text <p>We will get the National Health Service catching cancer on time, diagnosing it earlier and treating it faster so more patients survive this horrible set of diseases, including bladder cancer, and we will improve patients’ experience across the system.</p><p>Nationally, there is a focus on innovation and a move to develop new cancer tests. University Hospitals of North Midlands (UHNM) NHS Trust has been part of the Galleri trial of blood tests to identify cancer at the earliest stage. The trust is supporting the development of these trials and their adoptions as they are made available.</p><p>UHNM is working with primary care networks and other primary care stakeholders to outline a clear set of actions and milestones to improve referral practice, particularly for bowel, gynaecology and urology patients.</p> answering member constituency Bristol South answering member printed Karin Smyth question first answered 10/09/2024 11:26:18 answering member 4444 label Biography information for Karin Smyth
tabling member	5168

1726055

registered interest
date	30/08/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Parkinson's Disease: Newcastle-under-Lyme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to help ensure that people with Parkinson’s in Newcastle-under-Lyme constituency receive (a) an early diagnosis and (b) swift treatment.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Adam Jogee
uin	3452
answer	answer is ministerial correction date of answer 05/09/2024 answer text <p>NHS England’s RightCare toolkit and Getting It Right First Time programme aim to improve care for people with Parkinson’s disease by reducing variation and delivering care more equitably across the country.</p><p>The National Institute for Health and Care Excellence’s (NICE) guidance, Parkinson’s disease: Diagnosis and management in primary and secondary care, updated in 2017, sets out best practice for clinicians in the identification and treatment of Parkinson’s, in line with the latest available evidence. The guidance states that if Parkinson's is suspected, people should be referred quickly and untreated to a specialist with expertise in the differential diagnosis of this condition.</p><p>There are 27 specialised neurological treatment centres across the National Health Service in England, with the nearest to Newcastle-under-Lyme being in the University Hospitals of North Midlands, which provide access to neurological multidisciplinary teams to ensure that patients with Parkinson’s can receive specialised treatment and support, according to their needs.</p><p>We expect integrated care boards (ICBs) and NHS trusts to have due regard to relevant NICE guidelines. It is the responsibility of the ICBs, including the Staffordshire and Stoke-on-Trent ICB which covers Newcastle-under-Lyme, to make available appropriate provision to meet the health and care needs of their local population, in line with these NICE guidelines, including diagnosis and treatment.</p> answering member constituency Gorton and Denton answering member printed Andrew Gwynne question first answered 05/09/2024 09:55:07 answering member 1506 label Biography information for Andrew Gwynne
tabling member	5168

1726056

registered interest
date	30/08/2024
answering body	Department for Business and Trade
answering dept id	214
answering dept short name	Business and Trade
answering dept sort name	Business and Trade
hansard heading	Business: Staffordshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business and Trade, what plans he has to (a) meet the Staffordshire Chamber of Commerce to discuss further cooperation and (b) visit businesses in Newcastle-under-Lyme constituency.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Adam Jogee
uin	3453
answer	answer is ministerial correction date of answer 11/09/2024 answer text <p>DBT is committed to driving long-term, inclusive and secure economic growth in all parts of the country, and engagement with Mayors, businesses and communities in all regions, including the West Midlands, is therefore a priority.</p><p> </p><p>DBT officials are in regular contact with Staffordshire Chamber of Commerce colleagues, helping to support their local businesses. The Ministerial team's plans for engagement, including regional and local visits, are revisited regularly.</p> answering member constituency Harrow West answering member printed Gareth Thomas question first answered 11/09/2024 10:52:11 answering member 177 label Biography information for Gareth Thomas
tabling member	5168

1726057

registered interest
date	30/08/2024
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Russia: Sanctions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, how much tax was taken on the interest accrued on Russian assets frozen in UK banks in each of the last five years.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Adam Jogee
uin	3454
answer	answer is ministerial correction date of answer 09/09/2024 answer text <p>The Office of Financial Sanctions Implementation (OFSI)’s, part of HM Treasury, announced in its 2022-2023 Annual Review that between February 2022 and October 2023, £22.7 billion in frozen funds had been reported in relation to the Russia sanctions regime. OFSI does not disclose the value held by particular designated persons and so the figure is provided as a cumulative total of assets reported.</p><p> </p><p>Frozen assets are not transferred to HM Treasury and there is no change of ownership. Interest accrued on frozen assets remains subject to the asset freeze, and are to be frozen immediately by the person in possession or control of them. There is no obligation for a relevant institution to inform OFSI when it credits an account with interest and therefore OFSI does not hold this information.</p> answering member constituency Hampstead and Highgate answering member printed Tulip Siddiq question first answered 09/09/2024 10:00:11 answering member 4518 label Biography information for Tulip Siddiq
tabling member	5168

1726058

registered interest
date	30/08/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Trastuzumab Deruxtecan
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of Enhertu in reducing the number of women who lose their lives to breast cancer in (a) Newcastle-under-Lyme constituency and b) England.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Adam Jogee
uin	3455
answer	answer is ministerial correction date of answer 09/09/2024 answer text <p>Whilst we have made no specific assessment, the clinical trial evidence considered by the National Institute for Health and Care Excellence (NICE) shows that Enhertu increases how long people live and how long they have before their cancer gets worse compared with chemotherapy treatments used for HER2‑negative breast cancer. It is not, however, a curative treatment.</p><p>We understand from NICE that it is estimated that approximately 1,000 women in England would have been eligible for treatment with Enhertu, if NICE had been able to recommend it for use in the treatment of HER2-low breast cancer. Information at constituency level is not held.</p> answering member constituency Bristol South answering member printed Karin Smyth question first answered 09/09/2024 10:46:15 answering member 4444 label Biography information for Karin Smyth
tabling member	5168